Search research articles
Contact Us
Filters
Showing results (101-110 of 492) with videos related to
Page
of 50
Sort By:
Current Drug Targets
|
July 23, 2011
HGF/c-MET targeted therapeutics: novel strategies for cancer medicine
Timothy A Yap, Shahneen K Sandhu, Salma M Alam, et al.
The Oncologist
|
September 28, 2011
Revisiting the role of antiandrogen strategies in ovarian cancer
Dionysis Papadatos-Pastos, Konstantin J Dedes, Johann S de Bono, et al.
CA: a Cancer Journal for Clinicians
|
January 6, 2011
Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Timothy A Yap, Shahneen K Sandhu, Craig P Carden, et al.
The Journal of Pathology
|
October 11, 2013
Molecular pathology and prostate cancer therapeutics: from biology to bedside
Daniel Nava Rodrigues, Lisa M Butler, David Lorente Estelles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2009
Targeting the PI3K/AKT pathway for the treatment of prostate cancer
Debashis Sarker, Alison H M Reid, Timothy A Yap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2015
Reply to A. Addeo and A. Bahl
Howard I Scher, Glenn Heller, Arturo Molina, et al.
JCO Precision Oncology
|
January 5, 2024
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects
Zhulin Yin, Adrian P Mander, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2014
Circulating tumor cells: a multifunctional biomarker
Timothy A Yap, David Lorente, Aurelius Omlin, et al.
The Lancet. Oncology
|
June 13, 2015
Sequencing of agents in castration-resistant prostate cancer
David Lorente, Joaquin Mateo, Raquel Perez-Lopez, et al.
Molecular Cell
|
June 20, 2015
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y Feng, Johann S de Bono, Mark A Rubin, et al.
Page
of 50
Search research articles
Search
Showing results (101-110 of 492) with videos related to
Sort By:
Page
of 50
Current Drug Targets
|
July 23, 2011
HGF/c-MET targeted therapeutics: novel strategies for cancer medicine
Timothy A Yap, Shahneen K Sandhu, Salma M Alam, et al.
The Oncologist
|
September 28, 2011
Revisiting the role of antiandrogen strategies in ovarian cancer
Dionysis Papadatos-Pastos, Konstantin J Dedes, Johann S de Bono, et al.
CA: a Cancer Journal for Clinicians
|
January 6, 2011
Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Timothy A Yap, Shahneen K Sandhu, Craig P Carden, et al.
The Journal of Pathology
|
October 11, 2013
Molecular pathology and prostate cancer therapeutics: from biology to bedside
Daniel Nava Rodrigues, Lisa M Butler, David Lorente Estelles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2009
Targeting the PI3K/AKT pathway for the treatment of prostate cancer
Debashis Sarker, Alison H M Reid, Timothy A Yap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2015
Reply to A. Addeo and A. Bahl
Howard I Scher, Glenn Heller, Arturo Molina, et al.
JCO Precision Oncology
|
January 5, 2024
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects
Zhulin Yin, Adrian P Mander, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2014
Circulating tumor cells: a multifunctional biomarker
Timothy A Yap, David Lorente, Aurelius Omlin, et al.
The Lancet. Oncology
|
June 13, 2015
Sequencing of agents in castration-resistant prostate cancer
David Lorente, Joaquin Mateo, Raquel Perez-Lopez, et al.
Molecular Cell
|
June 20, 2015
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y Feng, Johann S de Bono, Mark A Rubin, et al.
Page
of 50